113 related articles for article (PubMed ID: 8938353)
1. In situ detection of DNA fragmentation and expression of bcl-2 in human neuroblastoma: relation to apoptosis and spontaneous regression.
Oue T; Fukuzawa M; Kusafuka T; Kohmoto Y; Imura K; Nagahara S; Okada A
J Pediatr Surg; 1996 Feb; 31(2):251-7. PubMed ID: 8938353
[TBL] [Abstract][Full Text] [Related]
2. Massive apoptosis detected by in situ DNA nick end labeling in neuroblastoma.
Ikeda H; Hirato J; Akami M; Suzuki N; Takahashi A; Kuroiwa M; Matsuyama S
Am J Surg Pathol; 1996 Jun; 20(6):649-55. PubMed ID: 8651343
[TBL] [Abstract][Full Text] [Related]
3. Bcl-2 oncoprotein expression and apoptosis in neuroblastoma.
Ikeda H; Hirato J; Akami M; Matsuyama S; Suzuki N; Takahashi A; Kuroiwa M
J Pediatr Surg; 1995 Jun; 30(6):805-8. PubMed ID: 7666311
[TBL] [Abstract][Full Text] [Related]
4. Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification.
Castle VP; Heidelberger KP; Bromberg J; Ou X; Dole M; Nuñez G
Am J Pathol; 1993 Dec; 143(6):1543-50. PubMed ID: 8256847
[TBL] [Abstract][Full Text] [Related]
5. Cellular death in neuroblastoma: in situ correlation of apoptosis and bcl-2 expression.
Hoehner JC; Hedborg F; Wiklund HJ; Olsen L; Påhlman S
Int J Cancer; 1995 Jul; 62(1):19-24. PubMed ID: 7601561
[TBL] [Abstract][Full Text] [Related]
6. Demonstration of apoptosis in neuroblastoma and its relationship to tumour regression.
Koizumi H; Wakisaka M; Nakada K; Takakuwa T; Fujioka T; Yamate N; Uchikoshi T
Virchows Arch; 1995; 427(2):167-73. PubMed ID: 7582247
[TBL] [Abstract][Full Text] [Related]
7. Increased Ras expression and caspase-independent neuroblastoma cell death: possible mechanism of spontaneous neuroblastoma regression.
Kitanaka C; Kato K; Ijiri R; Sakurada K; Tomiyama A; Noguchi K; Nagashima Y; Nakagawara A; Momoi T; Toyoda Y; Kigasawa H; Nishi T; Shirouzu M; Yokoyama S; Tanaka Y; Kuchino Y
J Natl Cancer Inst; 2002 Mar; 94(5):358-68. PubMed ID: 11880474
[TBL] [Abstract][Full Text] [Related]
8. Mass screening for neuroblastoma: quo vadis? A 9-year experience from the Pediatric Oncology Study Group of the Kyushu area in Japan.
Suita S; Zaizen Y; Sera Y; Takamatsu H; Mizote H; Ohgami H; Kurosaki N; Ueda K; Tasaka H; Miyazaki S; Sugimoto T; Kawakami K; Tsuneyoshi M; Yano H; Akiyama H; Ikeda K
J Pediatr Surg; 1996 Apr; 31(4):555-8. PubMed ID: 8801312
[TBL] [Abstract][Full Text] [Related]
9. The Relationship Between Apoptotic Activity and Prognostic Factors in Neuroblastomas.
Ekmekci S; Olgun N; Özer E
Turk Patoloji Derg; 2016; 32(2):99-104. PubMed ID: 27136108
[TBL] [Abstract][Full Text] [Related]
10. Study of bcl-2 protein expression and the apoptosis phenomenon in neuroblastoma.
Mejia MC; Navarro S; Pellin A; Castel V; Llombart-Bosch A
Anticancer Res; 1998; 18(2A):801-6. PubMed ID: 9615722
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis in peripheral neuroblastic tumors. Immunohistochemical expression of bcl-2 and p53 is related to DNA fragmentation.
Mejía C; Navarro S; Llombart-Bosch A
Histol Histopathol; 2007 Dec; 22(12):1365-70. PubMed ID: 17701916
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-I protects neuroblastoma against starvation-induced apoptosis and is associated with increased Bcl-2 expression.
Beierle EA; Strande LF; Chen MK
J Pediatr Surg; 2002 Mar; 37(3):472-6. PubMed ID: 11877670
[TBL] [Abstract][Full Text] [Related]
13. VEGF upregulates Bcl-2 expression and is associated with decreased apoptosis in neuroblastoma cells.
Beierle EA; Strande LF; Chen MK
J Pediatr Surg; 2002 Mar; 37(3):467-71. PubMed ID: 11877669
[TBL] [Abstract][Full Text] [Related]
14. Spatial association of apoptosis-related gene expression and cellular death in clinical neuroblastoma.
Hoehner JC; Gestblom C; Olsen L; Påhlman S
Br J Cancer; 1997; 75(8):1185-94. PubMed ID: 9099968
[TBL] [Abstract][Full Text] [Related]
15. Correlation of modified Shimada classification with MYCN and 1p36 status detected by fluorescence in situ hybridization in neuroblastoma.
Altungoz O; Aygun N; Tumer S; Ozer E; Olgun N; Sakizli M
Cancer Genet Cytogenet; 2007 Jan; 172(2):113-9. PubMed ID: 17213019
[TBL] [Abstract][Full Text] [Related]
16. trk A gene expression in neuroblastoma. The clinical significance of an immunohistochemical study.
Tanaka T; Hiyama E; Sugimoto T; Sawada T; Tanabe M; Ida N
Cancer; 1995 Sep; 76(6):1086-95. PubMed ID: 8625212
[TBL] [Abstract][Full Text] [Related]
17. Different genomic and metabolic patterns between mass screening-positive and mass screening-negative later-presenting neuroblastomas.
Nakagawara A; Zaizen Y; Ikeda K; Suita S; Ohgami H; Nagahara N; Sera Y; Akiyama H; Kawakami K; Uchino J
Cancer; 1991 Nov; 68(9):2037-44. PubMed ID: 1913552
[TBL] [Abstract][Full Text] [Related]
18. Expression of bcl-2 gene product in neuroblastoma.
Ramani P; Lu QL
J Pathol; 1994 Mar; 172(3):273-8. PubMed ID: 8195931
[TBL] [Abstract][Full Text] [Related]
19. [Studies on gene expression of bcl-2 and its correlation with tumor cell apoptosis as well as expression of p16 in human neuroblastoma].
Zhe X; Chen J; Liu T
Zhonghua Bing Li Xue Za Zhi; 1997 Oct; 26(5):289-92. PubMed ID: 10374338
[TBL] [Abstract][Full Text] [Related]
20. Neuroblastoma detected by mass screening: the Tumor Board's role in its treatment.
Okazaki T; Kohno S; Mimaya J; Hasegawa S; Urushihara N; Yoshida A; Kawano S; Kusafuka J; Horikoshi Y; Takashima Y; Aoki K; Hamazaki M
Pediatr Surg Int; 2004 Jan; 20(1):27-32. PubMed ID: 14689211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
